AD/PD 2019

During the 14th International Conference on Alzheimer's and Parkinson's Diseases, Dr Francesca Cormack (Director of Research and Innovation) and Nick Taptiklis (Head of Technology Strategy) presented new data at the poster sessions:

Manuel Bolano (Director, Business Development) was also on hand to discuss how the following CANTAB tools can be used in the detection, monitoring and treatment of Alzheimer's, Parkinson's and associated neurological disorders: